Recombinant Protein Therapy Market: Toxicity Screening, and Drug Discovery Will Witness the Fastest Expansion
Surged adoption of biologics and biosimilars in the treatment of chronic ailments such as diabetes, hemophilia, and cancer are expected to lend ample growth impetus towards the growth of recombinant protein market. Recombinant proteins also play an exemplary role in disease management of critical ailments such as joint disorders which markedly hamper the quality of life amongst patients round the globe. Besides genetic engineering and cell engineering techniques, recombinant protein therapy has emerged as a potential therapeutic option. However, prevailing bottlenecks such as high pricing brackets and high maintenance cost are likely to dampen growth considerably in the near future. Capitalizing on growing demands and applications, leading global providers are encouraged to direct ample resources towards R&D initiatives and clinical trials for novel protein therapeutics, thus bolstering growth in recombinant protein market . Besides novelties in protein strains, leading manufac...